July 8, 2020 — Many patients with severe coronavirus disease 2019 (COVID-19) remain unresponsive after surviving critical illness. Investigators led by a team at Massachusetts General Hospital (MGH) now describe a patient with severe COVID-19 who, despite prolonged unresponsiveness and structural brain abnormalities, demonstrated functionally intact brain connections and weeks later he recovered the ability to follow commands.

July 8, 2020 — Hologic, Inc. announced he U.S. launch of the SuperSonic MACH 40 ultrasound system, expanding the company’s suite of ultrasound technologies with its first premium, cart-based system. The new system features excellent image quality, standard-setting imaging modes, and is designed to enhance efficiency and accuracy.

July 8, 2020 — Changes outlined in new draft U.S.

Several drivers will contribute to the growth of the teleradiology market in terms of penetration, revenue and read volumes over the next five years

Last year was a record year for the global teleradiology reading services market, with revenues rising by 9 percent to $1.2 billion. The market is on course for solid growth over the next five years, tipping the market past $2 billion in 2024.

The rise in burnout among radiologists is a global phenomenon, and is especially prominent in breast imaging. Fortunately, long gone are the days when fears that artificial intelligence (AI) will replace radiologists dominated the discourse. 

As the nascent market for artificial intelligence (AI) in medical imaging develops, healthcare providers are faced with the question of how best to select, purchase and implement the rapidly expanding range of regulatory approved AI-enabled imaging applications and AI algorithms. 
Fujifilm’s Sonosite SII POC ultrasound system helps to keep crowded areas clearer with a small ultrasound footprint.

With the miniaturization of technology, improved ease of use, lower system cost, increased portability and greater access to training, the appeal of ultrasound continues to expand in point-of-care (POC) markets. Estimated growth in the POC ultrasound (POCUS) market is expected to exceed $3 billion globally by 2025,1,2 up from $1.3 billion in 2018.
Radiotherapy has been used to treat cancers for more than a century and continues to be utilized in cancer treatment plans today. Since the introduction of radiotherapy, clinicians have been working tirelessly to further refine treatments to better target cancer.

Everything has room for improvement, right? Right. When it comes to cancer care, it is no different. Researchers, drug companies and technology innovators are constantly working to improve efficiency and efficacy, racing to create the best and most far-reaching cancer treatments. Significant resources are being dedicated to a rapidly evolving form of cancer therapy that is designed to be more effective than other existing options. However, new innovations have introduced new challenges, and emerging treatments must adapt to overcome these barriers. 
Proton therapy has evolved, and future predictions include smaller systems, more sophisticated proton dosimetry and devices that manipulate the proton beam

The field of proton therapy is continuing to see explosive growth. In the past decade alone, technological advances have made proton therapy a more accessible, viable option for hospitals and radiotherapy centers. Moreover, clinical applications for proton therapy have evolved, enabling the treatment of a broad range of diseases. 
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now